Immunohistochemical Expression of M30, BCL-2, BAX, and Ki-67 in Pancreatic Ductal Adenocarcinoma: Association with Clinicopathological Features.

Demirciler Yavaş B, Yılmaz S

Open source

DOI
10.3390/diagnostics16203426
Published
2026 Oct 21
Container
Diagnostics (Basel, Switzerland)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/diagnostics16203426,
  title = {Immunohistochemical Expression of M30, BCL-2, BAX, and Ki-67 in Pancreatic Ductal Adenocarcinoma: Association with Clinicopathological Features.},
  author = {Demirciler Yavaş B and Yılmaz S},
  year = {2026},
  journal = {Diagnostics (Basel, Switzerland)},
  doi = {10.3390/diagnostics16203426},
  url = {https://doi.org/10.3390/diagnostics16203426}
}

RIS

TY  - JOUR
TI  - Immunohistochemical Expression of M30, BCL-2, BAX, and Ki-67 in Pancreatic Ductal Adenocarcinoma: Association with Clinicopathological Features.
AU  - Demirciler Yavaş B
AU  - Yılmaz S
PY  - 2026
JO  - Diagnostics (Basel, Switzerland)
DO  - 10.3390/diagnostics16203426
UR  - https://doi.org/10.3390/diagnostics16203426
ER  - 

APA

B, D. Y., & S, Y. (2026). Immunohistochemical Expression of M30, BCL-2, BAX, and Ki-67 in Pancreatic Ductal Adenocarcinoma: Association with Clinicopathological Features.. Diagnostics (Basel, Switzerland). https://doi.org/10.3390/diagnostics16203426

Source records